Presentation TCT 2014 Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani September 13, 2014
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Conference News TCT 2014 Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices September 13, 2014
News Conference News TCT 2013 Second-Generation TAVR Device Overcomes Issues of Current Valves October 31, 2013
Presentation TCT 2013 Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada) Presenter: Marian Hawkey October 29, 2013
News Conference News TCT 2012 TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone October 31, 2012
News Conference News TCT 2012 Mitral Valve-in-Valve Improves Outcomes in High-Risk Patients October 29, 2012
Presentation TCT 2012 Next-Generation Balloon-Expandable Technology: SAPIEN 3 Presenter: Josep Rodes-Cabau October 24, 2012
News Conference News TCT 2012 Registries Show Low Complication Rates With New Heart Valves October 23, 2012
News Conference News TCT 2012 PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use October 23, 2012
Presentation TCT 2012 Reduced incidence of bleedings, vascular complications and 30 days mortality with the Sapien Novaflex system: Results from a single center Tansfemoral-TAVI registry Presenter: Giovanni Sorropago, Eugenio Stabile, Armando Pucciarelli, Linda Cota, Angelo Cioppa, Marco Agrusta, Vittorio Ambrosini, Vincenzo Lucchetti, Paolo Rubino January 03, 2012
News Conference News PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years November 09, 2011
News Conference News Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement November 08, 2011